Cytosorbents (CTSO) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.25% |
| Dec 31, 2025 | -13.25% |
| Sep 30, 2025 | -15.19% |
| Jun 30, 2025 | -0.52% |
| Mar 31, 2025 | 2.80% |
| Dec 31, 2024 | 11.59% |
| Sep 30, 2024 | 10.76% |
| Jun 30, 2024 | 13.41% |
| Mar 31, 2024 | 8.72% |
| Dec 31, 2023 | 9.14% |
| Sep 30, 2023 | 6.79% |
| Jun 30, 2023 | 8.46% |
| Mar 31, 2023 | 15.22% |
| Dec 31, 2022 | 21.28% |
| Sep 30, 2022 | 22.89% |
| Jun 30, 2022 | 26.38% |
| Mar 31, 2022 | 58.63% |
| Dec 31, 2021 | 55.99% |
| Sep 30, 2021 | 54.33% |
| Jun 30, 2021 | 50.51% |
| Mar 31, 2021 | 55.86% |
| Dec 31, 2020 | 51.54% |
| Dec 31, 2019 | 26.45% |
| Sep 30, 2019 | 24.40% |
| Jun 30, 2019 | 20.40% |
| Mar 31, 2019 | 20.12% |
| Dec 31, 2018 | 53.25% |
| Sep 30, 2018 | 53.35% |
| Jun 30, 2018 | 63.61% |
| Mar 31, 2018 | 62.13% |
| Dec 31, 2017 | 48.48% |
| Sep 30, 2017 | 46.72% |
| Jun 30, 2017 | 50.13% |
| Mar 31, 2017 | 24.38% |
| Dec 31, 2016 | 35.50% |
| Sep 30, 2016 | 29.91% |
| Jun 30, 2016 | 26.90% |
| Dec 31, 2015 | 44.09% |